Curvebeam AI Ltd
ASX:CVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Curvebeam AI Ltd
ASX:CVB
|
US |
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
Aurora Corp
TWSE:2373
|
TW |
|
Macro Enterprises Inc
XTSX:MCR
|
CA |
|
Farm Pride Foods Ltd
ASX:FRM
|
AU |
|
I
|
Inhome Prime Properties Socimi SA
MAD:YIPP
|
ES |
|
Reach Resources Ltd
ASX:RR1
|
AU |
|
R
|
Raharja Energi Cepu Tbk PT
IDX:RATU
|
ID |
|
Veris Ltd
ASX:VRS
|
AU |
|
Fox Corp
NASDAQ:FOXA
|
US |
Cash Flow Statement
Cash Flow Statement
Curvebeam AI Ltd
| Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Stock-Based Compensation |
0
|
2
|
2
|
2
|
2
|
|
| Cash Interest Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
0
|
|
| Cash from Operating Activities |
(26)
N/A
|
(22)
+15%
|
(17)
+24%
|
(11)
+33%
|
(10)
+10%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+62%
|
(0)
+6%
|
(0)
-61%
|
(0)
+13%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
25
|
25
|
12
|
12
|
7
|
|
| Net Issuance of Debt |
13
|
0
|
(0)
|
(0)
|
0
|
|
| Other |
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
36
N/A
|
24
-34%
|
10
-56%
|
10
-1%
|
6
-43%
|
|
| Change in Cash | ||||||
| Effect of Foreign Exchange Rates |
(1)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
9
N/A
|
1
-86%
|
(6)
N/A
|
(1)
+77%
|
(5)
-243%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(26)
N/A
|
(22)
+16%
|
(17)
+23%
|
(12)
+32%
|
(10)
+12%
|
|